JVP invests $1m in US company NanoTectonica

This is the first time that an Israeli fund has invested in nanotechnology. The financing round was led by the worlds leading venture capital fund, Kleiner, Perkins, Caufield & Byers

Israeli venture capital fund Jerusalem Venture Partners (JVP) has invested about $1 million in US nanotechnology company NanoTectonica. This is the first time that an Israeli fund has invested in nanotechnology. Sources inform Globes that the financing round was led by Kleiner, Perkins, Caufield & Byers of the US, considered to be the worlds leading venture capital fund.

This is also the first time Kleiner, Perkins, Caufield & Byers has cooperated with an Israeli fund. Kleiner, Perkins, Caufield & Byers invested in Zaffire, set up by Near Margalit. That investment was made in cooperation with US communications company MRVC, whose controlling shareholders are Israelis

The partner who led the investment for Kleiner, Perkins, Caufield & Byers is Vinod Khosla, whom Forbes has named as the worlds best venture capital investor.

NanoTectonica is developing a technology that is supposed to revolutionize the printing of active circuits. Unlike costly and time-consuming conventional processes, NanoTectonicas technology will enable fast printing, without the need for photolithography or etching.

Launching a modern chip fab requires an initial investment of at least $4 million. The cost of using NanoTectonicas proprietary printing method is considerably lower.

NanoTectonicas founders and its basic technology come from MITs Media Labs. The companys management includes executives with extensive backgrounds in the electronics and semiconductors industries.

JVP would not comment on the report.

Published by Israel's Business Arena on 19 December, 2001

View comments in rows
Update by email about comments talkback
Your name
Please insert your name
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments

Twitter Facebook Linkedin RSS Newsletters Capital  Markets Conference 2017